Importance of MACC1 expression in breast cancer and its relationship with pathological prognostic markers

被引:7
|
作者
Soyleyici, Nevroz A. [1 ]
Aslan, Figen [2 ]
Avcikurt, Ayla S. [3 ]
Akgun, Gizem A. [4 ]
机构
[1] BaliKesir Univ, Inst Hlth Sci, Dept Pathol, Cagis Yerleskesi,Bigadic Yolu 17 Km Altieylul, BaliKesir, Turkey
[2] BaliKesir Univ, Dept Pathol, Sch Med, Cagis Yerleskesi,Bigadic Yolu 17 Km Altieylul, TR-10145 BaliKesir, Turkey
[3] BaliKesir Univ, Sch Med, Dept Med Biol, Cagis Yerleskesi,Bigadic Yolu 17 Km Altieylul, BaliKesir, Turkey
[4] Dumlupinar Univ, Sch Med, Dept Pathol, Merkez Kutahya, Turkey
关键词
Breast cancer; expression; Metastasis Associated Colon Cancer Gene 1; prognostic marker; COLON CANCER-1; POOR-PROGNOSIS; GROWTH-FACTOR; CARCINOMA; MET; ANGIOGENESIS; LEVEL;
D O I
10.4103/IJPM.IJPM_658_19
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Metastasis associated colon cancer gene 1 (MACC1) is a gene that was first described as a c-Met transcription regulator causing the progression of colon cancer. In this study, protein and messenger RNA (mRNA) expression of MACC1 in breast cancer and its relationship with clinicopathological prognostic parameters were investigated. Methods: Sixty-six cases with tumors underwent radical mastectomy for invasive ductal carcinoma and 25 control cases operated for mammoplasty were included in the study. In paraffin blocks of tumor and control tissues, MACC1 expression was investigated by the immunohistochemical method and Real-time polymerase chain reaction (Real-Time PCR). In addition, vascular endothelial growth factor (VEGF) expression was examined immunohistochemically in tumor tissues. The relationship between MACC1 expression in tumor tissues, clinicopathological prognostic parameters, and VEGF was investigated. Results: In this study, protein and mRNA expressions of MACC1 were found to be higher in tumor tissues compared with normal breast tissues. MACC1 protein expression was also associated with significant poor prognostic markers, such as high histologic grade, ER negativity, and HER2 positivity. However, there was no correlation between MACC1 expression and VEGF. Conclusion: According to these results, MACC1 expression may be a marker of breast carcinoma as well as an independent predictor of poor prognosis. In addition, MACC1 may not affect angiogenesis in breast cancer or even if it has an effect, it may not be associated with VEGF. However, it would be appropriate to support these results in a larger series by investigating in vivo and in vitro studies.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 50 条
  • [21] Investigation of MACC1 Gene Expression in Head and Neck Cancer and Cancer Stem Cells
    Evran, Ebru
    Sahin, Hilal
    Akbas, Kubra
    Cigdem, Sadik
    Gunduz, Esra
    CLINICAL AND INVESTIGATIVE MEDICINE, 2016, 39 (06): : S77 - S81
  • [22] LncRNA MACC1-AS1 associates with DDX5 to modulate MACC1 transcription in breast cancer cells
    Zheng, Guiyu
    Zhu, Yanmei
    Xu, Liqun
    Chen, Shaoying
    Zhang, Xiaona
    Li, Wei
    Chen, Weibin
    Zhou, Yanchun
    Gu, Wei
    ISCIENCE, 2023, 26 (09)
  • [23] Obesity, colorectal cancer and MACC1 expression: A possible novel molecular association
    Baehr, Ina
    Jaeschke, Lina
    Nimptsch, Katharina
    Janke, Juergen
    Herrmann, Pia
    Kobelt, Dennis
    Kielstein, Heike
    Pischon, Tobias
    Stein, Ulrike
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 60 (02)
  • [24] MACC1 expression is an indicator of recurrence in early-stage glottic cancer
    Makino, Takuma
    Orita, Yorihisa
    Gion, Yuka
    Tachibana, Tomoyasu
    Takao, Soshi
    Marunaka, Hidenori
    Miki, Kentaro
    Akisada, Naoki
    Akagi, Yusuke
    Yoshino, Tadashi
    Nishizaki, Kazunori
    Sato, Yasuharu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (04) : 392 - 398
  • [25] MACC1 promotes pancreatic cancer metastasis by interacting with the EMT regulator SNAI1
    Zhang, Xianglian
    Luo, Ya
    Cen, Yu
    Qiu, Xin
    Li, Jing
    Jie, Mengmeng
    Yang, Shiming
    Qin, Shanyu
    CELL DEATH & DISEASE, 2022, 13 (11)
  • [26] Correlation of MACC1 and MET Expression in Rectal Cancer after Neoadjuvant Chemoradiotherapy
    Kawamura, Mikio
    Saigusa, Susumu
    Toiyama, Yuji
    Tanaka, Koji
    Okugawa, Yoshinaga
    Hiro, Junichiro
    Uchida, Keiichi
    Mohri, Yasuhiko
    Inoue, Yasuhiro
    Kusunoki, Masato
    ANTICANCER RESEARCH, 2012, 32 (04) : 1527 - 1531
  • [27] Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients
    Muendlein, Axel
    Hubalek, Michael
    Geller-Rhomberg, Simone
    Gasser, Klaus
    Winder, Thomas
    Drexel, Heinz
    Decker, Thomas
    Mueller-Holzner, Elisabeth
    Chamson, Martina
    Marth, Christian
    Lang, Alois H.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (12) : 2134 - 2141
  • [28] Prognostic and clinicopathological significance of MACC1 expression in hepatocellular carcinoma patients: a meta-analysis
    Sun, Da-Wei
    Zhang, Ying-Yi
    Qi, Yue
    Liu, Gui-Qi
    Chen, Yu-Guo
    Ma, Jian
    Lv, Guo-Yue
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (04): : 4769 - 4777
  • [29] The Relationship between MACC1/c-Met/Cyclin D1 Axis Expression and Prognosis in ESCC
    Shi, Yan
    Li, Meng-Yan
    Wang, Hui
    Li, Chao
    Liu, Wen-Ying
    Gao, Yong-Mei
    Wang, Bo
    Song, Jia-Wei
    Ma, Yu-Qing
    ANALYTICAL CELLULAR PATHOLOGY, 2022, 2022
  • [30] Relationship between the expression of various markers and prognostic factors in breast cancer
    Anim, JT
    John, B
    Abdulsathar, SA
    Prasad, A
    Saji, T
    Akhtar, N
    Ali, V
    Al-Saleh, M
    ACTA HISTOCHEMICA, 2005, 107 (02) : 87 - 93